Skip to main content
Signal8

THOMPSON JOHN CRAIG

SEC insider (Form 3/4/5 filer). CIK 0001509643. Director at Esperion Therapeutics, Inc. (ESPR). 3 reported Form 4/5 transactions since Sep 2024; latest on Jul 13, 2026. Located in ANN ARBOR, MI.

Companies THOMPSON JOHN CRAIG has filed insider reports for

  • Esperion Therapeutics, Inc. (ESPR): Director
THOMPSON JOHN CRAIG profile photo

THOMPSON JOHN CRAIG

CIK: 0001509643

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Esperion Therapeutics, Inc. logo
ESPR

Esperion Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Esperion Therapeutics, Inc. logo
    ESPR

    Esperion Therapeutics, Inc.

    Jul 13, 2026
    Disposition
    Direct
    79.9K shares-
  • Esperion Therapeutics, Inc. logo
    ESPR

    Esperion Therapeutics, Inc.

    May 28, 2026
    Award
    Direct
    79.9K shares-
  • Esperion Therapeutics, Inc. logo
    ESPR

    Esperion Therapeutics, Inc.

    Jul 1, 2025
    Award

    Stock Option (right to buy)

    Direct
    40K shares-

1-3 of 3